News AI features in UK plan to reduce animal testing The UK government has set out an ambitious plan to phase out animal testing in scientific studies within five years.
R&D Recent breakthroughs in 3D bioprinting: A look at trends and... 3D bioprinting technology is bringing a new revolutionary wave to the healthcare industry.
Partner Content Partner Content SMi’s 3D Cell Culture Conference 2021 – Speakers Announced SMi’s 3D Cell Culture Conference 2021
Partner Content Partner Content Speaker interview MRC Harwell Institute ahead of SMi’s 3D Ce... Speaker interview MRC Harwell Institute
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
